MIDROPS - Trademark Details
Status: 700 - Registered
Serial Number
88199169
Registration Number
6170100
Word Mark
MIDROPS
Status
700 - Registered
Status Date
2020-10-06
Filing Date
2018-11-19
Registration Number
6170100
Registration Date
2020-10-06
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-06-04
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
FERRELL, STEVEN WAYNE
Statements
Goods and Services
Non-ionic surfactants as raw materials for use in the manufacture of industrial products, consumer and household products; Reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Chemicals, namely, buffer and standard solutions used in analytical chemistry
Goods and Services
Eye drops; Ophthalmic preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for ophthalmological use; Antibiotic preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of emulsions that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of micelle that facilitate the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Optic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Goods and Services
Manufacture of nano scale material to the order and specification of others for use in the manufacture of other goods
Goods and Services
Laboratory research in the field of pharmaceuticals; Laboratory research in the field of biotechnology; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Pseudo Mark
MI DROPS
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-12-06
Primary Code
005
First Use Anywhere Date
2015-05-03
First Use In Commerce Date
2015-05-03
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Gordon R. Moriarty
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0085532
Original Filing Date USPTO
2019-04-29
International Registration Number
1479965
International Registration Date
2019-04-29
International Status Code
480
International Renewal Date
2029-04-29
Madrid History Events | ||
Date | Code | Description |
2021-03-13 | PCBNP | PARTIAL CEASING OF EFFECT PROCESSED BY IB |
2019-06-18 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
2019-06-18 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
2021-01-06 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
2019-08-01 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
2019-04-29 | ACERT | AUTOMATICALLY CERTIFIED |
2019-04-29 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
2019-04-29 | APPST | IR CERTIFIED AND SENT TO IB |
2019-06-03 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
2019-05-28 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
2021-01-21 | CBMPP | CEASING OF EFFECT PROCESSED |
2021-01-21 | CBPSP | PARTIAL CEASING OF EFFECT NOTICE SENT TO IB |
Trademark Events
Event Date | Event Description |
2018-11-22 | NEW APPLICATION ENTERED IN TRAM |
2018-12-06 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-02-22 | ASSIGNED TO EXAMINER |
2019-02-22 | NON-FINAL ACTION WRITTEN |
2019-02-22 | NON-FINAL ACTION E-MAILED |
2019-02-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-03-21 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-03-28 | ASSIGNED TO LIE |
2019-04-02 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-04-02 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-04-23 | FINAL REFUSAL WRITTEN |
2019-04-23 | FINAL REFUSAL E-MAILED |
2019-04-23 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2019-04-25 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2019-04-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-04-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-04-26 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-05-15 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-06-04 | PUBLISHED FOR OPPOSITION |
2019-06-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-07-30 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-12-02 | TEAS EXTENSION RECEIVED |
2019-12-02 | EXTENSION 1 FILED |
2019-12-02 | EXTENSION 1 GRANTED |
2019-12-04 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-07-22 | TEAS STATEMENT OF USE RECEIVED |
2020-08-04 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-07-22 | USE AMENDMENT FILED |
2020-08-04 | STATEMENT OF USE PROCESSING COMPLETE |
2020-08-24 | SU - NON-FINAL ACTION - WRITTEN |
2020-08-24 | NON-FINAL ACTION E-MAILED |
2020-08-24 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-08-27 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-08-27 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-08-27 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-08-31 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2020-09-01 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2020-10-06 | REGISTERED-PRINCIPAL REGISTER |